This inventor holds 2 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignee: Haisco Pharmaceuticals Pte. Ltd.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Guobiao Zhang: Innovator in Pharmaceutical Chemistry
Introduction
Guobiao Zhang is a notable inventor based in Sichuan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways. With a total of 2 patents, his work is focused on innovative solutions for treating various diseases.
Latest Patents
One of Guobiao Zhang's latest patents involves a nitrile derivative that acts as an inhibitor of dipeptidyl peptidase 1. This compound, represented by a specific formula, includes various forms such as stereoisomers, deuterated products, co-crystals, solvates, or pharmaceutically acceptable salts. The compound exhibits dipeptidyl peptidase 1 inhibitory activity, making it a potential candidate for drug development aimed at treating obstructive airway diseases, bronchiectasis, cystic fibrosis, asthma, emphysema, and chronic obstructive pulmonary diseases.
Career Highlights
Guobiao Zhang is currently associated with Haisco Pharmaceuticals Pte. Ltd., where he continues to advance his research and development efforts. His work at this company has positioned him as a key player in the pharmaceutical industry, contributing to innovative drug solutions.
Collaborations
Guobiao Zhang collaborates with talented individuals such as Wenjing Wang and Jia Ni. Their combined expertise enhances the research and development initiatives within their projects.
Conclusion
Guobiao Zhang's contributions to pharmaceutical chemistry, particularly through his innovative patents, highlight his role as a significant inventor in the field. His work promises to impact the treatment of various respiratory diseases positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile